episode 686: COVID-19 clinical update #38 with Dr. Daniel Griffin
Daniel Griffin provides his weekly clinical report on COVID-19, including new post-exposure guidelines from CDC, clinical trials of Remdesivir and convalescent plasma, FDA EUA for baricitinib and Regeneron’s monoclonal antibody and more.
Hosts: Daniel Griffin and Vincent RacanielloSubscribe (free): iTunes, Google Podcasts, RSS, email
Become a patron of TWiV!
Links for this episode- WHO Solidarity trial for Remdesivir and other drugs (medRxiv)
- EUA for Baricitinib (FDA)
- EUA for Casirivimab and Imdevimab (FDA)
- RCT: No benefit of convalescent plasma (NEJM)
- Letters read on TWiV 686
- Timestamps by Jolene. Thanks!
Intro music is by Ronald Jenkees
Send your virology questions and comments to twiv@microbe.tv